Please sign in to follow a disease.

Glucose-galactose malabsorption

MONDO:0011731

Glucose-galactose malabsorption (GGM) is a very rare, potentially lethal, genetic metabolic disease characterized by impaired glucose-galactose absorption resulting in severe watery diarrhea and dehydration with onset inthe neonatal period.

Also known as: SGLT1 deficiency, glucose-galactose malabsorption, Complex carbohydrate intolerance, GGM, carbohydrate intolerance of glucose galactose, glucose galactose malabsorption deficiency, glucose/galactose malabsorption, monosaccharide malabsorption

161 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Glucose intolerance (130)

Broader categories

Disease (618) Metabolic disease (215) Hereditary disease (172) Digestive system disorder (141) Intestinal disorder (55) Inborn errors of metabolism (42) Human disease (14) Carbohydrate metabolism disease (3) Disease of genetic or genomic mechanism (2) Inborn carbohydrate metabolic disorder (2)

Trials to join now! 57 Not yet recruiting 25 Not yet finished but already full! 31 Completed 47 Terminated 1

Obesity drug cocktail tested for heart benefits – study halted early

Disease control Terminated

This study looked at whether using a combination of weight-loss medications could help people with obesity lose weight and improve the health of their blood vessels. It involved 128 adults aged 40-75 who were obese and had at least one heart risk factor. The study was stopped ear…

Phase: PHASE2 • Sponsor: University of Iowa • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

Glucose-galactose malabsorption

Sub-types

Broader categories

Obesity drug cocktail tested for heart benefits – study halted early